What Is a Normal RVSP and What Do the Results Mean?

A normal right ventricular systolic pressure (RVSP) for a healthy adult under 50 is roughly 27 mmHg, with most people falling somewhere between 16 and 39 mmHg. That number creeps upward with age, so what counts as “normal” for an 80-year-old would look different from what’s normal for a 30-year-old. The story gets more complicated when you look at what the research actually says about where risk begins, because the traditional cutoff used to flag a problem may be higher than the point where real health consequences start.

How RVSP Gets Measured

RVSP is almost always estimated during a standard echocardiogram, not measured directly. The technique relies on a tiny leak that most people have in their tricuspid valve, the valve between the right atrium and right ventricle. When blood leaks backward through that valve (tricuspid regurgitation), it creates a jet that the ultrasound’s Doppler mode can detect. The peak speed of that jet, plugged into a fluid-dynamics formula called the modified Bernoulli equation, gives the pressure difference across the valve. Add an estimate of right atrial pressure, and you get RVSP.¹

This approach has been the workhorse of cardiology since the 1980s, and it works well enough as a screening tool. But there’s an important catch: if you don’t have a measurable tricuspid regurgitation jet, the sonographer simply can’t estimate your RVSP. European guidelines recommend looking at other echocardiographic signs of elevated right-heart pressure when the jet is absent or too faint to measure reliably.² So a report that says “RVSP could not be estimated” doesn’t mean your pressure is fine; it means the test couldn’t get a reading.

Normal Values by Age

A large echocardiographic study established age-specific reference ranges that many clinicians still rely on. For adults younger than 50, the average RVSP was about 27 mmHg, with a normal range of roughly 16 to 39 mmHg. For those between 50 and 75, the average rose to about 30 mmHg with a range of 15 to 45 mmHg. And for adults older than 75, the average was close to 35 mmHg with a range stretching from 17 to 52 mmHg.³

The upward drift with age is real and well documented. Part of it reflects age-related stiffening of the pulmonary blood vessels and changes in left heart function that increase backpressure into the lungs. The practical takeaway is that a reading of 38 mmHg in a 78-year-old sits comfortably within the expected range, while the same number in a 35-year-old would be near the upper boundary and might warrant a second look.

Where the “Elevated” Cutoff Falls

Most clinical studies and heart-failure research use 40 mmHg as the line between normal and mildly elevated RVSP. Above that, the grading typically looks like this:

Mildly elevated: 40 to 49 mmHg
Moderately elevated: 50 to 59 mmHg
Severely elevated: 60 mmHg or higher

These tiers come from widely used research classifications and heart-failure registries.⁴ Some studies use slightly different thresholds; one large echocardiographic database defined pulmonary hypertension starting at an RVSP above 33 mmHg.⁵ The inconsistency matters, because whether your report reads “mild elevation” or “within normal limits” can depend on which threshold the interpreting cardiologist used.

Why Even Borderline Numbers Carry Risk

One of the more sobering findings in the RVSP literature is that you don’t have to hit the 40 mmHg cutoff for the number to matter. A large study of over 150,000 echocardiograms found that long-term mortality began climbing at an RVSP of about 30 mmHg. Even people in the third quintile (roughly 28 to 32 mmHg) had about a 40% higher death rate than those in the lowest quintile, after adjusting for age, sex, and left heart disease. At the severe end, people with an RVSP of 60 mmHg or above had nearly a tenfold higher adjusted risk of death.⁶

A separate analysis in JAMA Cardiology found that even “mild” echocardiographic pulmonary hypertension was associated with about a 65% higher risk of dying, even after accounting for heart failure and valve disease. That study pinpointed the onset of increased mortality risk at an RVSP of 27 mmHg and found the risk roughly doubled at 35 mmHg.⁷

This creates a gap between the clinical cutoff most labs report as “elevated” (40 mmHg) and the point where risk actually starts (somewhere around 27 to 30 mmHg). If your report says your RVSP is 34 and marks it as normal, that may be statistically true for your age group, but it doesn’t mean the number is risk-free. This is an area where the science has moved faster than the standard lab report.

How Accurate Is the Echo Estimate

Because RVSP from an echocardiogram is an estimate and not a direct measurement, it’s worth understanding how much the number on your report might differ from reality. The gold standard for measuring right-heart pressures is right heart catheterization, where a thin tube is threaded through a vein into the heart and pulmonary arteries.

A large comparison study found that Doppler echo and catheterization correlated well overall, with an average difference of only about 2 mmHg. That sounds reassuring, but the individual spread was wide: in any given patient, the echo estimate could be as much as 18 mmHg too high or 14 mmHg too low compared to the catheter reading.⁸ Another analysis found similar agreement limits of roughly plus or minus 19 mmHg and concluded that while echo is reliable for studying groups of patients, it can’t be trusted to make or exclude a diagnosis of pulmonary hypertension in a single person.⁹

The accuracy gets worse at higher pressures. In a pediatric study, echocardiography was inaccurate in about a quarter to a third of children whose actual right ventricular pressures were significantly elevated, with roughly equal rates of overestimation and underestimation.¹⁰ The message for patients is straightforward: an echo-derived RVSP is a useful screening number, but if a clinical decision hinges on whether your pressures are truly elevated, your doctor may recommend a catheterization to get the definitive answer.

Common Reasons RVSP Rises

An elevated RVSP is a downstream consequence, not a diagnosis in itself. It tells you the right side of the heart is working against more resistance than normal, but not why. The underlying causes fall into a few broad categories.

By far the most common cause is left heart disease. When the left ventricle doesn’t pump efficiently or the mitral valve leaks or stiffens, pressure backs up through the lungs and raises the load on the right ventricle. This is the mechanism behind a huge share of elevated RVSP readings in clinical practice, and it’s why your cardiologist will look carefully at left heart function before pursuing rarer explanations.

Chronic lung diseases like COPD also drive RVSP upward. Low oxygen levels cause the pulmonary blood vessels to constrict, a reflex that evolved to redirect blood toward better-ventilated parts of the lung. Over time, the vessel walls remodel and thicken permanently, locking in the elevated pressure even when oxygen levels improve.¹¹ Sleep apnea works through a similar intermittent-hypoxia pathway and is an underappreciated contributor to mildly elevated readings.

Blood clots in the lungs are another important cause. After an acute pulmonary embolism, most people’s pressures return to normal as the clot dissolves. But in a subset, the clot organizes into scar tissue and permanently blocks parts of the pulmonary vascular bed, a condition called chronic thromboembolic pulmonary hypertension (CTEPH). In one study, patients who developed CTEPH had dramatically higher RVSP on their initial echocardiogram (averaging about 76 mmHg) compared to those who recovered normally (about 39 mmHg), and RVSP at the time of the embolism was a significant predictor of who went on to develop the chronic condition.¹²

Less common causes include connective-tissue diseases like scleroderma, congenital heart defects, liver cirrhosis with portal hypertension, and the rare condition known as pulmonary arterial hypertension, where the small pulmonary arteries narrow for reasons that are sometimes genetic and sometimes unknown.

Temporary Spikes in Healthy People

Not every high reading points to disease. RVSP rises dramatically during vigorous exercise in perfectly healthy people, simply because the heart is pumping a much larger volume of blood through the lungs. A meta-analysis of over 1,600 athletes found that resting RVSP was about 3 mmHg higher in athletes than in non-athletes, a trivial difference. During exercise, however, the gap widened to about 11 mmHg higher in athletes.¹³

The extremes are striking. In a study of Ironman-level endurance athletes exercising above 20 METs, RVSP surged from a resting average of about 26 mmHg to around 62 mmHg, a rise of over 140%.¹⁴ These numbers would look alarming on a resting echocardiogram, but they fall back to normal once exercise stops and represent a healthy cardiovascular response, not a disease.

High altitude has a similar effect. Breathing thinner air triggers pulmonary vasoconstriction, pushing RVSP upward. Studies comparing cardiac function under different forms of hypoxia have consistently found higher RVSP and greater pulmonary vascular resistance than at sea level, both at rest and after exercise.¹⁵ If you live at high elevation or recently had an echo after intense exertion, a mildly elevated reading could reflect circumstance rather than pathology. Context matters.

What Happens After an Elevated Reading

If your echocardiogram flags a higher-than-expected RVSP, the first step isn’t panic. The cardiologist’s job is to figure out the “why,” which determines everything about how the finding is managed.

For many people, the answer is straightforward: the elevated RVSP is a side effect of a left-heart problem already under treatment, like heart failure or mitral valve disease. In those cases, treating the underlying condition is the strategy, and RVSP may come down as the primary issue improves. Serial echocardiograms over time can track whether RVSP is trending upward, stable, or improving with treatment.¹⁶

When the left heart looks normal and no obvious lung disease explains the elevated pressure, the workup gets more involved. Clinicians look at the full echocardiographic picture, including the size and function of the right ventricle, the shape of the interventricular septum, and whether the right atrium is dilated. These clues help determine whether a right heart catheterization is warranted.¹⁷ A catheterization is the only way to definitively measure pulmonary artery pressure and distinguish between different categories of pulmonary hypertension, each of which has a different treatment path.

Other tests that might enter the picture include a CT scan of the lungs to look for clots or parenchymal disease, pulmonary function tests to evaluate for COPD or interstitial lung disease, blood work for connective-tissue markers, and an overnight sleep study if obstructive sleep apnea is suspected. The evaluation is driven by the clinical context, not by the RVSP number alone.

Right Ventricular Coupling and Why Pressure Alone Isn’t Enough

Cardiologists increasingly recognize that RVSP by itself tells only half the story. What matters just as much is how well the right ventricle is coping with whatever pressure it faces. Two patients can have the same RVSP, say 55 mmHg, but vastly different outlooks depending on whether the right ventricle is still contracting forcefully or has started to fail.

This concept is sometimes called right ventricular–pulmonary artery coupling: the match between the ventricle’s pumping ability and the load it has to push against. Researchers have proposed several ways to assess this noninvasively, including ratios that combine a measure of right ventricular contraction (like TAPSE, or how far the tricuspid valve ring moves with each beat) with the estimated pulmonary artery pressure.¹⁸ When the ratio is preserved, the right ventricle is keeping up. When it drops, the ventricle is starting to decompensate, even if the pressure hasn’t changed.

You’re unlikely to see coupling ratios on a standard echo report yet, but these measures are gaining traction in heart-failure clinics and pulmonary hypertension centers. The reason this matters to patients is practical: a high RVSP with a well-functioning right ventricle is a fundamentally different clinical situation from a high RVSP with a weakening one, and the trajectory of the right ventricle often predicts symptoms and outcomes better than the pressure number does.

Obesity, Fluid Overload, and Other Confounders

Several common conditions can nudge RVSP upward without representing classical pulmonary vascular disease. Obesity increases blood volume and cardiac output, raises intra-abdominal pressure, and often coexists with sleep apnea, all of which push RVSP higher. A mildly elevated reading in a patient with a high BMI may be driven almost entirely by these mechanical and metabolic factors. Significant weight loss in such patients has been associated with measurable drops in pulmonary pressures.

Fluid overload from any cause, whether it’s kidney disease, aggressive IV fluids in a hospital setting, or decompensated heart failure, can temporarily inflate RVSP by expanding blood volume. An echocardiogram done during a fluid-overloaded state may show a reading that normalizes after diuresis. This is one reason cardiologists prefer to interpret RVSP in the context of the patient’s volume status rather than treating a single number as definitive.

Anemia is another underappreciated contributor. When hemoglobin is low, the heart compensates by increasing output, which raises flow through the pulmonary bed and can elevate RVSP. Correcting the anemia often brings the pressure back down. The broader point is that not every elevated RVSP reading requires a pulmonary hypertension workup; sometimes it requires treatment of the systemic condition driving it.

RVSP in Pregnancy

Pregnancy imposes major hemodynamic changes: blood volume increases by 30 to 50 percent, cardiac output rises substantially, and the pulmonary vasculature normally accommodates this extra flow by dilating. In most healthy women, RVSP stays within normal limits throughout pregnancy. But in women who already have some degree of pulmonary vascular disease, even undiagnosed, the increased volume load can unmask dangerously high pressures. Pulmonary arterial hypertension in pregnancy carries a historically very high mortality rate, reported in the range of 30 to 56 percent in older studies, though more recent series with earlier detection and aggressive management have improved those numbers somewhat.¹⁹

An elevated RVSP discovered incidentally on an echocardiogram during pregnancy calls for careful evaluation by a team experienced in both cardiology and maternal-fetal medicine. The challenge is distinguishing the normal physiologic rise in cardiac output from true pulmonary vascular disease, a distinction that sometimes requires catheterization if the clinical picture is ambiguous. For women with known pulmonary hypertension, pregnancy is generally considered high risk and requires specialized pre-conception counseling.